Skip to main content
OpenTrials
Completed

NCT Number: NCT02275013

Levosimendan Administration and Outcome in Cardiac Surgery

To assess the effects on outcome of levosimendan with respect to timing of its administration on the postoperative course of high-risk cardiac surgery patients in a retrospective observational study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Treatment of Left Heart Insufficiency in an Operative Setting of Cardiac Surgery

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Charité University Medicine

Berlin, State of Berlin, 10117, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients undergoing cardiac surgery between 2006 and 2013
  • levosimendan administration within 24 hours of postoperative ICU admission

Exclusion criteria

  • patients younger than 18

Treatment and study plan

Levosimendan

Drug

Primary outcomes

  1. In-hospital mortality

    Time frame: until discharge, an average of 3 weeks length of stay

  2. 1 year follow-up mortality

    Time frame: 1 year after surgery

Secondary outcomes

  1. Duration of mechanical ventilation

    Time frame: until discharge, an average of 3 weeks length of stay

  2. Incidence of renal dysfunction

    Time frame: until discharge, an average of 3 weeks length of stay

  3. Incidence of renal replacement therapy

    Time frame: until discharge, an average of 3 weeks length of stay

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Registry information

Important dates

Study start
2006
Primary completion
2013
Study completion
2013
First posted
Oct 27, 2014
Registry last updated
Oct 27, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.